Diebold Nixdorf, Incorporated (DBD)
(Real Time Quote from BATS)
$44.32 USD
-0.22 (-0.49%)
Updated May 20, 2024 11:32 AM ET
1-Strong Buy of 5 1
A Value B Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DBD 44.32 -0.22(-0.49%)
Will DBD be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for DBD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DBD
Zacks.com featured highlights Medpace, American Axle, Diebold Nixdorf, Euronet and Omnicom
5 Stocks With Upgraded Broker Ratings Worth Investing in Now
DBD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Computer and Technology Stocks Lagging Badger Meter (BMI) This Year?
What Makes Diebold Nixdorf, Incorporated (DBD) a Good Fit for 'Trend Investing'
Check Point (CHKP) Q1 Earnings & Sales Beat Expectations
Other News for DBD
What's Driving Riskified Ltd's Surprising 15% Stock Rally?
Bankart Partners with Diebold Nixdorf to Modernize its Payment Processing Platform Across Southeast Europe
Diebold, Bankart announce partnership
Amgen upgraded, Peloton downgraded: Wall Street's top analyst calls
D.A. Davidson Keeps Their Buy Rating on Diebold Nixdorf Inc (DBD)